Efficacy and safety of daily home-based transcranial direct current stimulation as adjunct treatment for bipolar depressive episodes: Double-blind sham-controlled randomized clinical trial

Overview of attention for article published in Frontiers in Psychiatry, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 16,792 followers.

“Conclusion: Even though we found no evidence for the efficacy of home-based tDCS for patients with BD, this tool was found to be a safe and tolerable treatment modality for BD.” 🤔🧐

20 Sep 2022

Reply Repost Favourite

Frontiers | Efficacy and safety of daily home-based transcranial direct current stimulation as adjunct treatment for bipolar depressive episodes: Double-blind sham-controlled randomized clinical trial https://t.co/6n1UQR76q5

20 Sep 2022

Reply Repost Favourite

New Research: Efficacy and safety of daily home-based transcranial direct current stimulation as adjunct treatment for bipolar depressive episodes: Double-blind sham-controlled randomized clinical trial: Background Although transcranial… https://t.co/0m0M

20 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.